Category archive
Browse every WeightEasy article in the Price and Access category.
Category pages gather broader article themes, which makes them useful for readers who are exploring a whole area like injection routines, side effects, or dose tracking rather than a single narrow question.
India's semaglutide market changed on March 20, 2026. The patent expired, and multiple Indian pharmaceutical companies launched their own versions of the drug including Obeda by Dr...
When Obeda launched in India in March 2026, the claim spread quickly: it is 60% cheaper than Ozempic. But is that actually true? And what does that difference mean for Indian patie...
If you are considering Obeda for weight loss, the first question most people ask is: what is this actually going to cost me every month? It is a fair question. Obeda is a prescript...
When Dr. Reddy's launched Obeda in India on March 21, 2026, one of the first questions people asked was: how much does it cost? For years, semaglutide was available only as importe...
March 2026 transformed India's GLP 1 landscape. Before the semaglutide patent expired, Indian patients had essentially one option: expensive imported Ozempic, if they could afford...